Fifth Third Bancorp acquired a new position in Revvity Inc. (NYSE:RVTY – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 30,649 shares of the company’s stock, valued at approximately $4,686,000.
Several other institutional investors have also recently made changes to their positions in the business. Pillar Financial Advisors LLC purchased a new stake in shares of Revvity during the third quarter worth about $29,000. Heritage Family Offices LLP bought a new stake in Revvity during the 3rd quarter valued at approximately $37,000. Global Retirement Partners LLC purchased a new position in Revvity in the 2nd quarter worth approximately $51,000. Root Financial Partners LLC purchased a new position in Revvity in the 3rd quarter worth approximately $64,000. Finally, EverSource Wealth Advisors LLC lifted its holdings in Revvity by 17.0% in the 1st quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock worth $66,000 after purchasing an additional 109 shares in the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.
Insider Buying and Selling
In other Revvity news, insider Maxwell Krakowiak sold 1,631 shares of Revvity stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $144.53, for a total value of $235,728.43. Following the sale, the insider owned 14,781 shares of the company’s stock, valued at $2,136,297.93. The trade was a 9.94% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Tajinder S. Vohra sold 7,330 shares of Revvity stock in a transaction that occurred on Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total value of $1,032,650.40. Following the completion of the sale, the insider directly owned 6,635 shares in the company, valued at approximately $934,738.80. The trade was a 52.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 9,045 shares of company stock valued at $1,281,439. 0.85% of the stock is owned by corporate insiders.
Revvity Trading Down 0.6%
Shares of Revvity stock opened at $147.95 on Wednesday. The firm has a market cap of $16.52 billion, a price-to-earnings ratio of 26.82, a PEG ratio of 2.61 and a beta of 1.08. The business has a 50-day moving average price of $151.26 and a 200-day moving average price of $114.68. The company has a quick ratio of 2.10, a current ratio of 2.65 and a debt-to-equity ratio of 0.36. Revvity Inc. has a twelve month low of $81.22 and a twelve month high of $171.74.
Revvity (NYSE:RVTY – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $1.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.08. Revvity had a return on equity of 8.64% and a net margin of 8.61%. The firm had revenue of $728.90 million for the quarter, compared to analysts’ expectations of $694.73 million. During the same period in the previous year, the firm posted $1.18 earnings per share. The business’s revenue was up 4.3% compared to the same quarter last year. Equities research analysts anticipate that Revvity Inc. will post 5.42 EPS for the current fiscal year.
Revvity Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, February 12th. Investors of record on Friday, January 22nd will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, January 22nd. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. Revvity’s dividend payout ratio is presently 12.39%.
Wall Street Analyst Weigh In
Several research analysts have weighed in on RVTY shares. UBS Group started coverage on Revvity in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $140.00 price target for the company. Bank of America reiterated a “neutral” rating on shares of Revvity in a research report on Wednesday, November 4th. Zacks Research raised shares of Revvity from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 4th. Royal Bank Of Canada boosted their target price on shares of Revvity from $135.00 to $172.00 and gave the stock a “sector perform” rating in a report on Wednesday, November 4th. Finally, Weiss Ratings upgraded shares of Revvity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Wednesday, November 11th. Six investment analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. According to MarketBeat, Revvity has an average rating of “Hold” and a consensus price target of $136.71.
Get Our Latest Stock Report on RVTY
Revvity Company Profile
Revvity, Inc. develops and supplies products and services for life sciences research and clinical diagnostics. Its offerings include instruments, reagents, software and related services used by pharmaceutical and biotechnology companies, academic and government research institutions, hospitals and clinical laboratories. The company’s work spans areas such as drug discovery and development, genetic testing, newborn screening and other diagnostic applications. Its technologies help researchers and healthcare providers analyze biological samples and generate information used in research and patient care.
Featured Stories
- Five stocks we like better than Revvity
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY – Free Report).
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
